The evolution and future of integrated evidence planning.

Journal: Expert review of pharmacoeconomics & outcomes research
Published Date: May 5, 2025

Abstract

INTRODUCTION: Integrated Evidence Planning (IEP) is a strategic approach that optimizes drug development and market access by ensuring evidence generation aligns with regulatory, clinical, and market needs. The increasing integration of advanced technologies, including artificial intelligence/machine learning (AI/ML), natural language processing (NLP), and generative AI is set to revolutionize IEP by enhancing decision-making and improving patient access.

Authors

  • Won Chan Lee
    RWE/HEOR/ES, Axtria, Inc, Berkeley Heights, USA.
  • Chris Blanchette
    Clinical Data Science & Evidence, Novo Nordisk Inc, Plainsboro, USA.
  • Shibani Pokras
    Global RWE and Health Outcomes, Vaccines, GlaxoSmithKlineUpper Providence, USA.
  • Javed Shaikh
    RWE/HEOR/ES, Axtria, Inc, Hyderabad, India.
  • Jared Miller
    RWE/HEOR/ES, Axtria, Inc, Berkeley Heights, USA.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals